|
|
|
| home > white papers > Planning the Execution of a Viral Clearance Study - Eurofins BioPharma Product Testing |
|
|
 WHITE PAPERS |
|
Eurofins BioPharma Product Testing
|
|
Planning the Execution of a Viral Clearance Study
|
|
Viral clearance studies are a necessary component of any regulatory submission for clinical trials or commercial product approval for all biopharmaceutical products. These studies are performed to evaluate the capability of the purification process to remove or inactivate viruses that could potentially contaminate the starting material. They are complex studies that require substantial financial and personnel resources, as well as specialized scientific expertise to perform. As such, viral clearance studies are often performed at a qualified contract testing laboratory rather than in-house. When multiple parties are involved in this process, clear communication and a comprehensive understanding of the approach and timeline is critical.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Almirall partners with the Chemical Institute of Sarrià (IQS) to bring pharmacy students’ training closer to real industry
The agreement will allow those studying the bachelor’s degree in
Pharmacy in IQS-URL to get training in actual pharmaceutical
manufacturing facilities for the first time
More info >> |
|
 |
White Papers |
 |
|
Pharmaceutical Companies: Outsourcing Combination Product Manufacturing
Phillips-Medisize
Combination products are therapeutics that combine two or more products (drug/device, biologics/device, biologics/drugs, or drug/device/biologics), regulated and sold as a single unit. Examples of combination products include drug-coated implantable devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
More info >> |
|
|
|
